Download FREE Report Sample
Download Free sampleUnfractionated Heparin (UFH) is a fast-acting blood thinner that works together with antithrombin, a natural protein in the body, to block clot formation. Specifically, UFH binds to antithrombin and enhances its ability to inhibit two of the body?s most potent clotting factors ? factor Xa and factor IIa ? usually within minutes. As with all forms of heparin, UFH doesn?t break down clots, but it keeps them from growing and stops new ones from forming. This allows the body the time necessary to gradually dissolve existing blood clots.Unfractionated Heparin Market can be devided by source (Porcine and Bovine), by Injection type (IV Injection and Subcutaneous Injection), and by disease indication (Venous Thromboembolism, Cardioversion of Atrial Fibrillation, and Pulmonary Embolism & Arterial Embolism).
Unfractionated Heparin Market aims to provide a comprehensive presentation of the global market for Unfractionated Heparin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Unfractionated Heparin. Unfractionated Heparin Market contains market size and forecasts of Unfractionated Heparin in global, including the following market information:
Global Unfractionated Heparin Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Unfractionated Heparin Market Sales, 2018-2023, 2024-2029, (MT)
Global top five Unfractionated Heparin companies in 2022 (%)
The global Unfractionated Heparin market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Porcine Unfractionated Heparin Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Unfractionated Heparin include Baxter International Inc., B. Braun Melsungen AG, Fresenius SE Co. KGaA, LEO Pharma A/S, Sagent Pharmaceuticals and Pfizer Inc, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Unfractionated Heparin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Unfractionated Heparin Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Unfractionated Heparin Market Segment Percentages, by Type, 2022 (%)
Porcine Unfractionated Heparin
Bovine Unfractionated Heparin
Global Unfractionated Heparin Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Unfractionated Heparin Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Unfractionated Heparin Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Unfractionated Heparin Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Unfractionated Heparin revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Unfractionated Heparin revenues share in global market, 2022 (%)
Key companies Unfractionated Heparin sales in global market, 2018-2023 (Estimated), (MT)
Key companies Unfractionated Heparin sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Baxter International Inc.
B. Braun Melsungen AG
Fresenius SE Co. KGaA
LEO Pharma A/S
Sagent Pharmaceuticals
Pfizer Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Unfractionated Heparin, market overview.
Chapter 2: Global Unfractionated Heparin market size in revenue and volume.
Chapter 3: Detailed analysis of Unfractionated Heparin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Unfractionated Heparin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Unfractionated Heparin capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy